Ticker
TVRDCompany Name
TVARDI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 223.09M | $ 424K | $ -2.31M | $ 0 | 0.84% |
3/31/2025 | $ 248.44M | $ 0 | $ -1.91M | $ 0 | 0.77% |
12/31/2024 | $ 23.44M | $ 0 | $ -3.6M | $ 0 | 15.38% |
9/30/2024 | $ 17.97M | $ 1K | $ 34.48M | $ 0 | -191.9% |
6/30/2024 | $ 18.02M | $ 1.12M | $ 35.18M | $ 0 | -201.38% |
3/31/2024 | $ 41.02M | $ 1.12M | $ 35.79M | $ 0 | -89.96% |
12/31/2023 | $ 54.12M | $ 1.68M | $ 36.47M | $ 0 | -70.5% |
9/30/2023 | $ 64.29M | $ 1.7M | $ 0 | $ 0 | -2.64% |
6/30/2023 | $ 159.53M | $ 686K | $ 0 | $ 0 | -0.43% |
3/31/2023 | $ 224.03M | $ 868K | $ 0 | $ 0 | -0.39% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for TVARDI THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 699K ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 723.06M ]
(=) Shareholder Yield [ -0.1% ]
Minimum
Jun 30, 2024
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.49K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.13% |